Morning After Pill May Combat Cancer Cells
Groundbreaking research reveals the morning after pill's unexpected potential in cancer prevention, with scientists discovering levonorgestrel's ability to combat deadly diseases.
Groundbreaking research reveals the morning after pill's unexpected potential in cancer prevention, with scientists discovering levonorgestrel's ability to combat deadly diseases.
A landmark policy change will make emergency contraception available free from pharmacies across the UK, breaking down barriers to reproductive healthcare.
Major pharmacy chains including Boots and Superdrug are now offering free emergency contraception without prescription in groundbreaking NHS scheme.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
Groundbreaking medical imaging uncovers alarming side effects of popular weight-loss drugs Ozempic and Wegovy that patients need to know about.
Groundbreaking research reveals GLP-1 agonists like Ozempic and Wegovy may cause misleading results on CT and PET scans, potentially hiding cancers and leading to dangerous misdiagnoses.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Warehouse giant Costco is now offering substantial discounts on popular weight loss medications Ozempic and Wegovy, making groundbreaking treatments more accessible to consumers across the UK.
In a landmark decision, US regulators have approved the first generic version of mifepristone, potentially transforming reproductive healthcare access and reducing costs across America.
US regulators approve first generic version of medication abortion drug mifepristone, sparking renewed debate as presidential candidate RFK Jr voices opposition
Leading medical bodies call for permanent safe home abortion services in Britain, citing overwhelming evidence of effectiveness and patient preference.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
New research debunks the long-standing myth that contraceptive pills cause significant weight gain. Experts explain the science behind hormonal contraception and its actual effects on your body.
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
Medical authorities sound alarm about unapproved use of leucovorin for autism treatment after prominent doctor's claims about 'miracle pill' results. Exclusive investigation reveals growing concerns among healthcare professionals.
Exclusive: A UK woman's persistent headaches and fatigue were repeatedly attributed to her contraceptive pill by her GP. After demanding a scan, she was diagnosed with a life-threatening brain tumour, sparking calls for improved medical vigilance.
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Medical experts reveal why miracle weight-loss drugs like Ozempic are failing to address the psychological roots of emotional eating, calling for integrated mental health support alongside pharmaceutical treatments.
Groundbreaking research reveals that blockbuster weight-loss jabs do more than suppress appetite—they may fundamentally change the brain's response to food, offering new hope for tackling compulsive eating disorders.
A groundbreaking pill from Retro Biosciences promises to reverse brain aging and combat dementia. Early human trials show potential to revolutionise Alzheimer's treatment. Discover the science behind this medical marvel.
A new oral weight loss drug, Orforglipron, shows staggering results in a major clinical trial, offering a powerful and convenient alternative to injectable treatments for obesity.
A revolutionary new weight loss pill, Survodutide, is making waves in medical trials, with manufacturers boasting it could be twice as effective as blockbuster drugs like Ozempic and Wegovy.
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.